Three new 18F labeled fluoroalkyl tyrosine derivatives, O-(2-[18F] fluoroethyl)-α- methyltyrosine (FEMT,[18F] 2), O-(2-[18F] fluoroethyl)-2-l-azatyrosine (FEAT,[18F] 3), O-(2- [18F] fluoroethyl)-l-tyrosineamide (FETA,[18F] 4) have been synthesized and radiofluorinated with 5–34% decay-corrected yield. In vitro studies were carried out in U-138 MG human glioblastoma. Cellular uptake of new tracers was compared to clinically ...